Reference
Canadian labelling for all JAK inhibitors to include risks of serious heart-related problems, fatal blood clots and cancer Internet Document : 8 Nov 2022. Available from: URL: https://recalls-rappels.canada.ca/en/alert-recall/canadian-labelling-all-jak-inhibitors-include-risks-serious-heart-related-problems
Rights and permissions
About this article
Cite this article
Canadian labelling for JAK inhibitors updated with risks of serious AEs. Reactions Weekly 1932, 3 (2022). https://doi.org/10.1007/s40278-022-27368-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-27368-2